Unitedhealth Group IncUNH
Price$367.08Intrinsic value$401.719% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $401.71median of 6 methods · middle span $320-$535based on filings through 30 Jun 2026
Market Price $367.08Price as of 30 Sep 2026
Margin of Safety +9.4%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 49.3% (near-term consensus, capped) · years 2–5: -3.5%/yr (balance of the path).5.3% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 6-2.2%Yr 7-0.9%Yr 80.4%Yr 91.7%Yr 103.0%
-3.5% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)-1.3%
Discount rate (cost of equity) 8.3%
Volatility vs market (adjusted beta)0.75

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetUnitedhealth Group IncUNHHealth Care
Valuation
P/E23.6×
P/S0.8×
P/B3.3×
EV / Revenue0.9×
EV / EBITDA—
Profitability
Gross margin—
Operating margin4.8%
Net margin3.1%
FCF margin5.2%
Returns
ROE13.5%
ROA4.6%
ROIC9.5%
Growth
Revenue growth (YoY)12.5%
5-yr fwd EPS growth17.1%
Financial strength
Debt / Equity0.70×
Current ratio0.78×
Altman Z-Score3.0
Interest coverage—
Dividend yield1.2%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.